License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association website.
Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.

Print | Bookmark | Email | Font Size: + | –

October 5, 2015 - Revised: 09.30.16

bioTheranostics Cancer TYPE ID (CM00015, V4)

Effective November 19, 2012, Cancer TYPE ID, an RT-PCR 92-gene assay, has been assigned a new identifier to reflect the changes in the test. To bill for Cancer TYPE ID services, please provide the following claim information:

Claims received prior to 01/01/2016: CPT code 81479 – unlisted molecular pathology procedure
Claims received 01/01/2016 and forward CPT code 81540 - Oncology (tumor of unknown origin) mRNA gene expression of 92 genes
Enter '1' in the Days/Unit field
Enter Z-Code™ Identifier in the comment/narrative field for the following claim field/types:
- Loop 2300 NTE01 for Part A or Loop 2400 or SV101-7 field for Part B
- Submit Z-Code™ Identifier on an attachment to the claim form for paper claim (Form locator 80 for Part A or Box 19 for Part B)
Select the appropriate diagnosis code:
- ICD-9-CM Code:
  - 153.5 Malignant Neoplasm of Appendix Vermiformis
  - 153.9 Malignant Neoplasm of Colon Unspecified Site
  - 155.0 Malignant Neoplasm of Liver Primary
  - 155.2 Malignant Neoplasm of Liver Not Specified As Primary or Secondary
  - 157.2 Malignant Neoplasm of Tail of Pancreas
  - 157.8 Malignant Neoplasm of Other Specified Sites of Pancreas
  - 157.9 Malignant Neoplasm of Pancreas Part Unspecified
  - 158.0 Malignant Neoplasm of Retroperitoneum
  - 162.0 Malignant Neoplasm of Trachea
  - 162.2 Malignant Neoplasm of Main Bronchus
  - 162.3 Malignant Neoplasm of Upper Lobe Bronchus or Lung
  - 162.5 Malignant Neoplasm of Lower Lobe Bronchus or Lung
  - 162.8 Malignant Neoplasm of Other Parts of Bronchus or Lung
  - 162.9 Malignant Neoplasm of Bronchus and Lung Unspecified
  - 171.0 Malignant Neoplasm of Connective and Other Soft Tissue of Head Face and Neck
  - 171.9 Malignant Neoplasm of Connective and Other Soft Tissue Site Unspecified
  - 172.5 Malignant Melanoma of Skin of Trunk Except Scrotum
  - 174.4 Malignant Neoplasm of Upper-Outer Quadrant of Female Breast
  - 174.5 Malignant Neoplasm of Lower-Outer Quadrant of Female Breast
  - 174.8 Malignant Neoplasm of Other Specified Sites of Female Breast
  - 174.9 Malignant Neoplasm of Breast (Female) Unspecified Site
  - 183.0 Malignant Neoplasm of Ovary
  - 185 Malignant Neoplasm of Prostate
  - 188.5 Malignant Neoplasm of Bladder Neck
  - 188.9 Malignant Neoplasm of Bladder Part Unspecified
  - 189.0 Malignant Neoplasm of Kidney Except Pelvis
  - 195.0 Malignant Neoplasm of Head Face and Neck
  - 196.0 - 196.9 Secondary and Unspecified Malignant Neoplasm of Lymph Nodes of Head Face and Neck - Secondary and Unspecified Malignant Neoplasm of Lymph Nodes Site Unspecified
  - 197.0 Secondary Malignant Neoplasm of Lung
  - 197.5 Secondary Malignant Neoplasm of Large Intestine and Rectum
  - 197.6 Secondary Malignant Neoplasm of Retroperitoneum and Peritoneum
  - 197.7 Malignant Neoplasm of Liver Secondary
  - 198.0 Secondary Malignant Neoplasm of Kidney
  - 198.2 Secondary Malignant Neoplasm of Skin
  - 198.3 Secondary Malignant Neoplasm of Brain and Spinal Cord
  - 198.5 Secondary Malignant Neoplasm of Bone and Bone Marrow
  - 198.6 Secondary Malignant Neoplasm of Ovary
  - 198.89 Secondary Malignant Neoplasm of Other Specified Sites
  - 199.0 Disseminated Malignant Neoplasm
  - 199.1 Other Malignant Neoplasm of Unspecified Site
  - 202.87 Other Malignant Lymphomas Involving Spleen
  - 230.8 Carcinoma In Situ of Liver and Biliary System
  - 230.9 Carcinoma In Situ of Other and Unspecified Digestive Organs
  - 231.2 Carcinoma In Situ of Bronchus and Lung
  - 239.0 Neoplasm of Unspecified Nature of Digestive System
  - 239.1 Neoplasm of Unspecified Nature of Respiratory System
  - 239.2 Neoplasm of Unspecified Nature of Bone Soft Tissue and Skin
  - 239.3 Neoplasm of Unspecified Nature of Breast
  - 239.4 Neoplasm of Unspecified Nature of Bladder
  - 239.5 Neoplasm of Unspecified Nature of Other Genitourinary Organs
  - 239.6 Neoplasm of Unspecified Nature of Brain
  - 239.7 Neoplasm of Unspecified Nature of Endocrine Glands and Other Parts of Nervous System
  - 239.89 Neoplasms of Unspecified Nature, Other Specified Sites
  - 239.9 Neoplasm of Unspecified Nature Site Unspecified
  - 511.81 Malignant Pleural Effusion
- ICD-10-CM codes:
  - C18.1-Malignant neoplasm of appendix
  - C18.9-Malignant neoplasm of colon, unspecified
  - C22.0-Liver cell carcinoma
  - C22.2-Hepatoblastoma
  - C22.3-Angiosarcoma of liver
  - C22.4-Other sarcomas of liver
  - C22.7-Other specified carcinomas of liver
  - C22.8-Malignant neoplasm of liver, primary, unspecified as to type
  - C22.9-Malignant neoplasm of liver, not specified as primary or secondary
  - C25.2-Malignant neoplasm of tail of pancreas
  - C25.7-Malignant neoplasm of other parts of pancreas
  - C25.8-Malignant neoplasm of overlapping sites of pancreas
  - C25.9-Malignant neoplasm of pancreas, unspecified
  - C48.0-Malignant neoplasm of retroperitoneum
  - C33-Malignant neoplasm of trachea
  - C34.01-Malignant neoplasm of right main bronchus
  - C34.02-Malignant neoplasm of left main bronchus
  - C34.11-Malignant neoplasm of upper lobe, right bronchus or lung
  - C34.12-Malignant neoplasm of upper lobe, left bronchus or lung
  - C34.31-Malignant neoplasm of lower lobe, right bronchus or lung
  - C34.32-Malignant neoplasm of lower lobe, left bronchus or lung
  - C34.2-Malignant neoplasm of middle lobe, bronchus or lung
  - C34.81-Malignant neoplasm of overlapping sites of right bronchus and lung
  - C34.82-Malignant neoplasm of overlapping sites of left bronchus and lung
  - C34.91-Malignant neoplasm of unspecified part of right bronchus or lung
  - C34.92-Malignant neoplasm of unspecified part of left bronchus or lung
  - C47.0-Malignant neoplasm of peripheral nerves of head, face and neck
  - C49.0-Malignant neoplasm of connective and soft tissue of head, face and neck
  - C47.9-Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified
  - C49.9-Malignant neoplasm of connective and soft tissue, unspecified
  - C43.51-Malignant melanoma of anal skin
  - C43.52-Malignant melanoma of skin of breast
  - C43.59-Malignant melanoma of other part of trunk
  - D03.51-Melanoma in situ of anal skin
  - D03.52-Melanoma in situ of breast (skin) (soft tissue)
  - D03.59-Melanoma in situ of other part of trunk
  - C50.411-Malignant neoplasm of upper-outer quadrant of right female breast
  - C50.412-Malignant neoplasm of upper-outer quadrant of left female breast
  - C50.511-Malignant neoplasm of lower-outer quadrant of right female breast
  - C50.512-Malignant neoplasm of lower-outer quadrant of left female breast
  - C50.811-Malignant neoplasm of overlapping sites of right female breast
  - C50.812-Malignant neoplasm of overlapping sites of left female breast
  - C50.911- Malignant neoplasm of unspecified site of right female breast
  - C50.912- Malignant neoplasm of unspecified site of right female breast
  - C56.1- Malignant neoplasm of right ovary
  - C56.2- Malignant neoplasm of left ovary
  - C61- Malignant neoplasm of prostate
  - C67.5- Malignant neoplasm of bladder neck
  - C67.9- Malignant neoplasm of bladder, unspecified
  - C64.1- Malignant neoplasm of right kidney, except renal pelvis
  - C64.2- Malignant neoplasm of left kidney, except renal pelvis
  - C76.0- Malignant neoplasm of head, face and neck
  - C77.0- Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
  - C77.1- Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes
  - C77.2- Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
  - C77.3- Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes
  - C77.4- Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes
  - C77.5- Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
  - C77.8- Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions
  - C77.9- Secondary and unspecified malignant neoplasm of lymph node, unspecified
  - C78.01- Secondary malignant neoplasm of right lung
  - C78.02- Secondary malignant neoplasm of left lung
  - C78.5- Secondary malignant neoplasm of large intestine and rectum
  - C78.6- Secondary malignant neoplasm of retroperitoneum and peritoneum
  - C78.7- Secondary malignant neoplasm of liver and intrahepatic bile duct
  - C79.01- Secondary malignant neoplasm of right kidney and renal pelvis
  - C79.02- Secondary malignant neoplasm of left kidney and renal pelvis
  - C79.2- Secondary malignant neoplasm of skin
  - C79.31- Secondary malignant neoplasm of brain
  - C79.49- Secondary malignant neoplasm of other parts of nervous system
  - C79.51- Secondary malignant neoplasm of bone
  - C79.52- Secondary malignant neoplasm of bone marrow
  - C79.61- Secondary malignant neoplasm of right ovary
  - C79.62- Secondary malignant neoplasm of left ovary
  - C79.89- Secondary malignant neoplasm of other specified sites199.0 Disseminated Malignant Neoplasm
  - C80.0-Disseminated malignant neoplasm, unspecified
  - C45.9-Mesothelioma, unspecified
  - C80.1-Malignant (primary) neoplasm, unspecified
  - C82.57-Diffuse follicle center lymphoma, spleen
  - C84.97-Mature T/NK-cell lymphomas, unspecified, spleen
  - C84.A7-Cutaneous T-cell lymphoma, unspecified, spleen
  - C84.Z7-Other mature T/NK-cell lymphomas, spleen
  - C85.17-Unspecified B-cell lymphoma, spleen
  - C85.27-Mediastinal (thymic) large B-cell lymphoma, spleen
  - C85.87-Other specified types of non-Hodgkin lymphoma, spleen
  - C85.97-Non-Hodgkin lymphoma, unspecified, spleen
  - C86.1-Hepatosplenic T-cell lymphoma (Alpha-beta and gamma delta types)
  - D01.5-Carcinoma in situ of liver, gallbladder and bile ducts
  - D01.7-Carcinoma in situ of other specified digestive organs
  - D01.9-Carcinoma in situ of digestive organ, unspecified
  - D02.21-Carcinoma in situ of right bronchus and lung
  - D02.22-Carcinoma in situ of left bronchus and lung
  - D49.0-Neoplasm of unspecified behavior of digestive system
  - D49.1-Neoplasm of unspecified behavior of respiratory system
  - D49.2-Neoplasm of unspecified behavior of bone, soft tissue, and skin
  - D49.3-Neoplasm of unspecified behavior of breast
  - D49.4-Neoplasm of unspecified behavior of bladder
  - D49.5-Neoplasm of unspecified behavior of other genitourinary organs (end dated 09/30/2016)
  - D49.511-Neoplasm of unspecified behavior right kidney
  - D49.512-Neoplasm of unspecified behavior left kidney
  - D49.6-Neoplasm of unspecified behavior of brain
  - D49.7-Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
  - D49.89-Neoplasm of unspecified behavior of other specified sites
  - D49.9-Neoplasm of unspecified behavior of unspecified site
  - J91.0-Malignant pleural effusion

Note: MolDX expects this test to ONLY be ordered by the treating physician.

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

AMA Disclaimer of Warranties and Liabilities.

CMS Disclaimer

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

bioTheranostics Cancer TYPE ID (CM00015, V4)

spacer